ViralProtec Announces Purchase Order With California Hospital
ROCHESTER, NY — (Marketwired) — 12/03/13 — NaturalNano, Inc. (OTCBB: NNAN) () announced today that the US Patent & Trademark Office has issued a patent to the Company which covers the use of NNAN-s proprietary Halloysite NanoTubes (HNT) in NanoComposite Method of Manufacturing.NaturalNano-s CEO James Wemett commented, "With the issuance of this US Patent, NNAN continues to expand and protect its proprietary uses for HNT, in this case, as a nano-filler. As our patent portfolio contin
ROCHESTER, NY — (Marketwired) — 08/20/13 — NaturalNano, Inc. (OTCQB: NNAN) () announced today financial results for the Second Quarter. During the second quarter, NNAN sales line increased 680% compared to second quarter in 2012 led by increased sales growth in NaturalNano-s patented Halloysite Nanotube (HNT) products.CEO James Wemett said, "NaturalNano-s HNT business made steady progress during the quarter driven by our continued collaboration with Fiabila S.A. to supply HNT for their
ROCHESTER, NY — (Marketwired) — 04/16/13 — NaturalNano, Inc. (OTCBB: NNAN) () announced that Dr. Michael King, of Cornell University, published his most recent study featuring the use of NaturalNano-s Halloysite Natural Tubes (HNT) in Journal of Nanomaterials ().The Study demonstrated that the capture of circulating tumor cells (CTCs) in blood can be targeted more effectively by the incorporation of HNT onto the surface of devices used for the capture of CTCs in blood. King-s Lab has been de
ROCHESTER, NY — (Marketwire) — 12/05/12 — NaturalNano, Inc. (OTCBB: NNAN) () announced that Fiabila has placed additional orders for NaturalNano-s Halloysite Tube Technology (HNT). NaturalNano-s HNT are environmentally friendly components that are incorporated into a range of the Fiabila produced nail polish products.NaturalNano-s CEO, James Wemett, said, "NaturalNano is very gratified with the continuing relationship with Fiabila and the commercial success shown to date in the Fiabila
ROCHESTER, NY — (Marketwire) — 10/12/12 — . (OTCBB: NNAN) () announced today that Dr. Michael King of Cornell University will present their recent work today at the First NEMB Venice Workshop on Cancer Nanotechnology in Venice, Italy. ()This Nanobiotechnology presentation will demonstrate that the capture of circulating tumor cells (CTCs) in blood can be targeted more effectively by the incorporation of NaturalNano-s Halloysite Natural Tubes (HNT) onto the surface of devices. These devices a
ROCHESTER, NY — (Marketwire) — 07/24/12 — NaturalNano, Inc. (OTCBB: NNAN) announced that the US Patent & Trademark Office has issued to the Company a patent covering the use of NNAN-s proprietary Halloysite NanoTubes (HNT) in polymeric composite materials including Nano-particle Fillers as a key strengthening component to enhance the performance.NaturalNano-s CEO James Wemett commented, "With the issuance of this US Patent NNAN continues to expand and protect the commercial applicat
